ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests

May 31, 1974

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008